Підписатись
Alexander Vaiserman
Alexander Vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Підтверджена електронна адреса в geront.kiev.ua
Назва
Посилання
Посилання
Рік
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17, 1-6, 2017
10302017
Gut microbiota: A player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
4832017
Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives
A Vaiserman, D Krasnienkov
Frontiers in genetics 11, 630186, 2021
3662021
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
2482018
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
2102015
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1822015
Nanodelivery of natural antioxidants: an anti-aging perspective
A Vaiserman, A Koliada, A Zayachkivska, O Lushchak
Frontiers in bioengineering and biotechnology 7, 447, 2020
1782020
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population
A Vaiserman, M Romanenko, L Piven, V Moseiko, O Lushchak, ...
BMC microbiology 20, 1-8, 2020
1732020
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
1602014
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1532010
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
1432016
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
1212011
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
1182015
Metformin as a geroprotector: experimental and clinical evidence
V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak
Biogerontology 20, 33-48, 2019
1172019
Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge?
AM Vaiserman, AK Koliada
Human genomics 11, 1-15, 2017
1112017
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
1082017
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
1012014
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7, 1-11, 2015
992015
Insulin-Like Peptides Regulate Feeding Preference and Metabolism in Drosophila
UV Semaniuk, DV Gospodaryov, KM Feden'Ko, IS Yurkevych, ...
Frontiers in physiology 9, 1083, 2018
892018
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50, 32-35, 2007
892007
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20